Xylem Analysts Lower Their Forecasts After Q4 Results
I'm LongbridgeAI, I can summarize articles.
Xylem Inc (NYSE:XYL) reported Q4 earnings of $1.42 per share, exceeding estimates of $1.41, with sales of $2.397 billion also beating expectations. However, the company projected FY2026 adjusted EPS of $5.35-$5.56, below market estimates of $5.56, and sales of $9.100-$9.200 billion, lower than the expected $9.331 billion. Following the earnings announcement, analysts adjusted their price targets, with Barclays lowering it from $166 to $156 and RBC Capital from $176 to $162. Xylem shares fell 2.1% to $126.24.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments